Fall 2005

IMPACT OF HELICOBACTER PYLORI ON PROGNOSIS OF PATIENTS WITH ACUTE CORONARY SYNDROME

Rahime Eskandarian, Shahrokh Moosavi, Mehdi Babai, Jafar Toussy, Raheb Ghorbani, Mojtaba Malek, Mohsen Shiasi, Behroz Momeni, Ali Ghasemi, Azade Vatani, Mehrdad Zahmatkesh

Abstract


Abstract
INTRODUCTION: Coronary artery disease (CAD) is the main cause of mortality in
industrial and developing countries. New risk factors including infections are under
investigation as potential factors. One of these infectious agents is Helicobacter pylori,
which has been investigated in numerous studies. This study was designed in view of the
controversies surrounding the impact of Helicobacter pylori on the prognosis of patients with
acute coronary syndrome (ACS).
METHODS: All patients with ACS including unstable angina and myocardial infarction who
were referred to Fatemieh Hospital between 20 February 2003 and 19 February 2004 and
were admitted to the CCU ward were enrolled in this cohort study. A total of 411 patients
with ACS were evaluated for Helicobacter pylori serologically, and the occurrence of cardiac
events needing angioplasty or coronary surgery was assessed.
RESULTS: Mean age of patients was 59.97±38.12 years and 56% of them were male. The
serology test for Helicobacter pylori infection was positive in 45.6±12.38%, negative in
43.8%, and borderline in 10.6% of patients. 191 patients had unstable angina and 220
patients had myocardial infarction. In a one-month follow-up, 10% of the patients developed
cardiac events and PCI or CABG was performed in 6.1% (16.1% totally). One-month
occurrence of cardiac events in the group with Helicobacter pylori infection was 11.9% vs.
19.3% in the group without infection (χ2 =3.078, P=0.079).
DISCUSSION: This prospective study showed that Helicobacter pylori infection has no
effect on short term prognosis of patients with ACS.
ARYA Journal, 2005, 1(3): 164-169
Keywords • Helicobacter pylori • Acute coronary syndrome • Prognosis

Full Text:

PDF XML

Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 4.0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.